S Dooley, R LLorente, K Jones, J Ford, E Mellon - Neuro-oncology, 2019 - europepmc.org
PURPOSE Despite the common finding of pseudoprogression or true progression one
month after primary chemoradiotherapy for glioblastoma, there are few studies evaluating …